Eran Broshy, Director at Magellan Health, holds 14.36K shares in Certara (Ticker: CERT), holds 70.02K shares in Theravance Biopharma (Ticker: TBPH), holds 9.64K shares in Magellan Health (Ticker: MGLN). Most recently, Eran Broshy Bought ― shares of Certara on Aug 23, 2023 for an estimated value of 79.06K.